Pantoprazole
Revision Date : 2-3-2021
Approved: TC,KOH
Alert
Short- and long-term safety data in infants are limited but there have been several safety concerns with long term usage in adults.
The bioavailability of the in-house pharmacy suspension made from the contents of the capsule may be less (up to 25% less) than that of the tablet itself. Dose may need to be adjusted if no clinical response.
Indication
Treatment of gastroesophageal reflux disease (GORD)
Post-operative prophylaxis in congenital tracheoesophageal fistula and oesophageal atresia (role unclear)
| 